| Literature DB >> 28917524 |
Takashi Kuramoto1, Mayuko Yokoe2, Naofumi Kunisawa3, Kana Ohashi4, Takahito Miyake4, Yuki Higuchi2, Kazuto Yoshimi2, Tomoji Mashimo2, Miyuu Tanaka5, Mitusru Kuwamura5, Shuji Kaneko4, Saki Shimizu3, Tadao Serikawa6, Yukihiro Ohno3.
Abstract
Tremor dominant Kyoto (Trdk) is an autosomal dominant mutation that appeared in F344/NSlc rats mutagenized with N-ethyl-N-nitrosourea (ENU). In this study, we characterized and genetically analyzed F344-Trdk/+ heterozygous rats. The rats exhibited a tremor that was especially evident around weaning but persisted throughout life. The tremors of F344-Trdk/+ rats were attenuated by drugs effective against essential tremor (ET) but not drugs used to treat Parkinson's disease-related tremor, indicating that the pharmacological phenotype of F344-Trdk/+ rats was similar to human ET. Using positional candidate approach, we identified the Trdk mutation as a missense substitution (c. 866T>A, p. I289N) in Kcnn2, which encodes the SK2 subunit of the small-conductance Ca2+-activated K+ channel. In vitro electrophysiological studies revealed that the I289N mutation diminished SK2 channel activity. These findings demonstrate that F344-Trdk/+ rats represent a novel model of ET, and strongly suggest that Kcnn2 is the causative gene for the tremor phenotype in F344-Trdk/+ rats.Entities:
Keywords: ENU mutagenesis; Model animal; Rats; SK2 channel; Tremor
Mesh:
Substances:
Year: 2017 PMID: 28917524 DOI: 10.1016/j.brainres.2017.09.012
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252